Ardelyx Inc (ARDX)

$5.86 +0.03 (0.51%)
Market Cap 1.42B
Revenue (ttm) 333.62M
Net Income (ttm) -39.14M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -11.73%
Debt to Equity Ratio 1.31
Volume 2,887,200
Avg Vol 3,672,346
Day's Range N/A - N/A
Shares Out 242.97M
Stochastic %K 53%
Beta 0.66
Analysts Strong Sell
Price Target $11.82

Company Profile

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. The company was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in Ju...

Industry: Biotechnology
Sector: Healthcare
Phone: 510 745 1700
Address:
400 Fifth Avenue, Suite 210, Waltham, United States
Food4Thought
Food4Thought Nov. 15 at 5:24 AM
$ARDX Q3 reporting is mostly done. First quarter in a while where the ratio has been this close to each other for inflows versus outflows. Might explain why SP has not been able to break out. For now, I will await the court decision and then re-access my position size from there. Best of luck to all longs! ARDX will get to where we think it will eventually and all of us have to weigh opportunity costs.
0 · Reply
TaZMaNiDEviL
TaZMaNiDEviL Nov. 14 at 10:38 PM
$ARDX Thanks to the ARDX family I will be closing on my third investment property on Dec 31st. Also closed out the semester with a 4.0 gpa. Graduation is next year and I can’t wait to be back full time kicking ass with my favorite group of traders. #SaluteToThisGroupsFoundationMembers. #YouKnowTheDrill
5 · Reply
imlivinit
imlivinit Nov. 14 at 10:28 PM
$ARDX Ok, up it is. Enjoy the weekend all. Look forward to hearing Mike Raab interviewed in London next week. For those with a dog, mine learned this and-will practice up till Monday.
0 · Reply
ToadTrader
ToadTrader Nov. 14 at 9:11 PM
$ARDX While some will express frustrations with recent price action, reality is that it is "HOLDING".... For Now (??).... And then what? WEll... I can't really say, beyond that it is likely to "do" one of three things: Move up.... Move down.... Stay the same (within the current range??). In the meantime, I watch the NEWS.... Gov't.... Social Politics.... World.... and then too, upcoming Holidays and then, the weather! All the while, a General Market flow... (QQQ) down some 4% over last two weeks.... Tech Stocks sagging off to the low side.... So..... I'll take this time to study my own status; mindset; and goal in messing with the Market! LOL Try to take care of the parts I "think" I have some influences towards, then get on back here, come Monday (God Willing!) and test the waters, once again! Find your Peace in your part of the world! CHEERS!
1 · Reply
Diddysjury
Diddysjury Nov. 14 at 9:02 PM
$ARDX where is the volume wowza
0 · Reply
FerreroRocher
FerreroRocher Nov. 14 at 9:00 PM
$ARDX Is it Monday yet?
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 14 at 7:50 PM
💎 LiquidTheta® Live Actionable Trade Asset: $ARDX Contracts: $ARDX January 15, 2027 $7 Calls Scale in: $1.43- $1.75 Scale out: $5.57-$9.54 Profit Potential : 230% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
donkeykongreturns
donkeykongreturns Nov. 14 at 7:44 PM
$ARDX Blackburn is a key figure in this -> https://www.youtube.com/watch?v=pkbdShdRujU
0 · Reply
donkeykongreturns
donkeykongreturns Nov. 14 at 7:12 PM
$ARDX Read this and imagine the political implications when the Democrats entire midterm strategy is healthcare. They just shut down the government over the argument that the Republicans are going to hurt healthcare access, but this decision (PLT access) is the result of PPACA era legislation. When the game begins on healthcare, Republicans have their new legislation on deck, PLT access as an example of how the past era's legislation failed and an alternative, innovative, approach to chronic health along with some drugs/treatments (look at the timing on certain announcements) ready to go. If you turn government into a health and services organization, the political parties will fight over who provides and manages these services most effectively. At the end of the day, it's an argument. You can see the argument forming.
3 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:16 PM
Hedge Alert Live - Protect Your Portfolio Contract: $ARDX $5.00 Put · NOV 21, 2025 Exp Entry Price: $0.05 - $0.11 Exit Price Target: $0.20 Profit Margin: +80% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Latest News on ARDX
Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week

Nov 7, 2025, 4:05 PM EST - 7 days ago

Real-World Evidence Studies of XPHOZAH® (tenapanor) Demonstrate Patient Satisfaction and Reduction in Serum Phosphate with XPHOZAH in Data Presented at ASN Kidney Week

Ardelyx to Participate at the Jefferies Global Healthcare Conference in London

Nov 5, 2025, 8:00 AM EST - 9 days ago

Ardelyx to Participate at the Jefferies Global Healthcare Conference in London

Ardelyx: Impressive Q3 Record Growth - Why I Buy

Nov 5, 2025, 4:24 AM EST - 9 days ago

Ardelyx: Impressive Q3 Record Growth - Why I Buy

Ardelyx: A Long Overdue Rally

Nov 4, 2025, 3:32 PM EST - 10 days ago

Ardelyx: A Long Overdue Rally

Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference

Nov 4, 2025, 8:00 AM EST - 10 days ago

Ardelyx President and Chief Executive Officer Mike Raab to Participate in the Wedbush Rewind American Society of Nephrology 2025 Investor Conference

Ardelyx, Inc. (ARDX) Q3 2025 Earnings Call Transcript

Oct 30, 2025, 11:06 PM EDT - 15 days ago

Ardelyx, Inc. (ARDX) Q3 2025 Earnings Call Transcript

Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Oct 30, 2025, 4:01 PM EDT - 15 days ago

Ardelyx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology's 2025 Annual Meeting

Oct 28, 2025, 8:01 AM EDT - 17 days ago

Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology's 2025 Annual Meeting

Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology's Kidney Week

Oct 21, 2025, 8:00 AM EDT - 24 days ago

Ardelyx Announces Four Abstracts Accepted for Poster Presentations at the American Society of Nephrology's Kidney Week

Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025

Oct 13, 2025, 8:35 AM EDT - 4 weeks ago

Ardelyx to Report Third Quarter 2025 Financial Results on October 30, 2025

Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer

Oct 13, 2025, 8:30 AM EDT - 4 weeks ago

Ardelyx Appoints Experienced Finance Executive, Sue Hohenleitner, as Chief Financial Officer

Ardelyx, Inc. (ARDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 8, 2025, 10:11 AM EDT - 2 months ago

Ardelyx, Inc. (ARDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Ardelyx, Inc. (ARDX) Presents At Citi's Biopharma Back To School Conference Transcript

Sep 3, 2025, 4:42 PM EDT - 2 months ago

Ardelyx, Inc. (ARDX) Presents At Citi's Biopharma Back To School Conference Transcript

Ardelyx to Participate in Upcoming Investor Conferences

Aug 25, 2025, 8:00 AM EDT - 2 months ago

Ardelyx to Participate in Upcoming Investor Conferences

Ardelyx: Improved Outlook For Ibsrela And Xphozah

Aug 15, 2025, 6:17 AM EDT - 3 months ago

Ardelyx: Improved Outlook For Ibsrela And Xphozah

Ardelyx, Inc. (ARDX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 8:11 PM EDT - 3 months ago

Ardelyx, Inc. (ARDX) Q2 2025 Earnings Call Transcript

Ardelyx Announces Changes to the Executive Leadership Team

Aug 4, 2025, 4:08 PM EDT - 3 months ago

Ardelyx Announces Changes to the Executive Leadership Team

Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 4, 2025, 4:01 PM EDT - 3 months ago

Ardelyx Reports Second Quarter 2025 Financial Results and Provides Business Update

Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025

Jul 21, 2025, 8:00 AM EDT - 4 months ago

Ardelyx to Report Second Quarter 2025 Financial Results on August 4, 2025

Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer

Jun 2, 2025, 4:05 PM EDT - 5 months ago

Ardelyx Appoints Mike Kelliher Chief Business Officer and James P. Brady Chief Human Resources Officer

Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025

May 21, 2025, 8:00 AM EDT - 6 months ago

Ardelyx to Participate at the Jefferies Global Healthcare Conference 2025

Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference

May 6, 2025, 8:01 AM EDT - 6 months ago

Ardelyx Presents Data Supporting IBSRELA® (tenapanor) at Digestive Disease Week 2025 Conference

Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty

May 2, 2025, 10:07 AM EDT - 7 months ago

Ardelyx: Revenue Misses And Losses Widen Amid XPHOZAH Uncertainty

Ardelyx, Inc. (ARDX) Q1 2025 Earnings Call Transcript

May 1, 2025, 10:06 PM EDT - 7 months ago

Ardelyx, Inc. (ARDX) Q1 2025 Earnings Call Transcript

Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update

May 1, 2025, 4:01 PM EDT - 7 months ago

Ardelyx Reports First Quarter 2025 Financial Results and Provides Business Update

Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

Apr 29, 2025, 8:00 AM EDT - 7 months ago

Ardelyx Appoints Merdad Parsey, M.D., Ph.D. to its Board of Directors

Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference

Apr 24, 2025, 8:01 AM EDT - 7 months ago

Ardelyx Announces Three Abstracts Accepted for Poster Presentations at Digestive Disease Week 2025 Conference

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025

Apr 17, 2025, 8:00 AM EDT - 7 months ago

Ardelyx to Report First Quarter 2025 Financial Results on May 1, 2025

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings

Apr 10, 2025, 4:02 PM EDT - 7 months ago

Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) to be Presented at the National Kidney Foundation Spring Clinical Meetings

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings

Mar 31, 2025, 4:03 PM EDT - 8 months ago

Ardelyx to Share a Post-Hoc Analysis of the OPTIMIZE Study Supporting XPHOZAH® (tenapanor) at the National Kidney Foundation Spring Clinical Meetings

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award

Mar 13, 2025, 8:02 AM EDT - 8 months ago

Ardelyx Announces the First Recipients of Derek Forfang Patient Advocate Award

Undercovered Dozen: Ardelyx, Aviva, Nutrien, Heartland Express +

Mar 1, 2025, 8:30 AM EST - 9 months ago

Undercovered Dozen: Ardelyx, Aviva, Nutrien, Heartland Express +

HTLD NTR

Tenapanor Approved in China for Hyperphosphatemia

Feb 26, 2025, 7:00 AM EST - 9 months ago

Tenapanor Approved in China for Hyperphosphatemia

Ardelyx: Limited Pipeline, Rising Costs, And Uncertain Growth Ahead (Downgrade)

Feb 24, 2025, 2:28 PM EST - 9 months ago

Ardelyx: Limited Pipeline, Rising Costs, And Uncertain Growth Ahead (Downgrade)

3 Biotech/Healthcare Names Under $10 I Am Buying Now

Feb 21, 2025, 4:21 PM EST - 9 months ago

3 Biotech/Healthcare Names Under $10 I Am Buying Now

GERN MRNA PSNL TEM

Ardelyx, Inc. (ARDX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 2:32 PM EST - 9 months ago

Ardelyx, Inc. (ARDX) Q4 2024 Earnings Call Transcript

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Feb 20, 2025, 7:30 AM EST - 9 months ago

Ardelyx Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference

Feb 19, 2025, 8:01 AM EST - 9 months ago

Ardelyx to Present at the TD Cowen 45th Annual Health Care Conference

Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025

Jan 30, 2025, 4:30 PM EST - 10 months ago

Ardelyx to Report Full Year and Fourth Quarter 2024 Financial Results on February 20, 2025

Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities

Jan 13, 2025, 8:03 AM EST - 10 months ago

Ardelyx Provides Update on Increasing Commercial Momentum and 2025 Strategic Priorities

Food4Thought
Food4Thought Nov. 15 at 5:24 AM
$ARDX Q3 reporting is mostly done. First quarter in a while where the ratio has been this close to each other for inflows versus outflows. Might explain why SP has not been able to break out. For now, I will await the court decision and then re-access my position size from there. Best of luck to all longs! ARDX will get to where we think it will eventually and all of us have to weigh opportunity costs.
0 · Reply
TaZMaNiDEviL
TaZMaNiDEviL Nov. 14 at 10:38 PM
$ARDX Thanks to the ARDX family I will be closing on my third investment property on Dec 31st. Also closed out the semester with a 4.0 gpa. Graduation is next year and I can’t wait to be back full time kicking ass with my favorite group of traders. #SaluteToThisGroupsFoundationMembers. #YouKnowTheDrill
5 · Reply
imlivinit
imlivinit Nov. 14 at 10:28 PM
$ARDX Ok, up it is. Enjoy the weekend all. Look forward to hearing Mike Raab interviewed in London next week. For those with a dog, mine learned this and-will practice up till Monday.
0 · Reply
ToadTrader
ToadTrader Nov. 14 at 9:11 PM
$ARDX While some will express frustrations with recent price action, reality is that it is "HOLDING".... For Now (??).... And then what? WEll... I can't really say, beyond that it is likely to "do" one of three things: Move up.... Move down.... Stay the same (within the current range??). In the meantime, I watch the NEWS.... Gov't.... Social Politics.... World.... and then too, upcoming Holidays and then, the weather! All the while, a General Market flow... (QQQ) down some 4% over last two weeks.... Tech Stocks sagging off to the low side.... So..... I'll take this time to study my own status; mindset; and goal in messing with the Market! LOL Try to take care of the parts I "think" I have some influences towards, then get on back here, come Monday (God Willing!) and test the waters, once again! Find your Peace in your part of the world! CHEERS!
1 · Reply
Diddysjury
Diddysjury Nov. 14 at 9:02 PM
$ARDX where is the volume wowza
0 · Reply
FerreroRocher
FerreroRocher Nov. 14 at 9:00 PM
$ARDX Is it Monday yet?
1 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 14 at 7:50 PM
💎 LiquidTheta® Live Actionable Trade Asset: $ARDX Contracts: $ARDX January 15, 2027 $7 Calls Scale in: $1.43- $1.75 Scale out: $5.57-$9.54 Profit Potential : 230% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
donkeykongreturns
donkeykongreturns Nov. 14 at 7:44 PM
$ARDX Blackburn is a key figure in this -> https://www.youtube.com/watch?v=pkbdShdRujU
0 · Reply
donkeykongreturns
donkeykongreturns Nov. 14 at 7:12 PM
$ARDX Read this and imagine the political implications when the Democrats entire midterm strategy is healthcare. They just shut down the government over the argument that the Republicans are going to hurt healthcare access, but this decision (PLT access) is the result of PPACA era legislation. When the game begins on healthcare, Republicans have their new legislation on deck, PLT access as an example of how the past era's legislation failed and an alternative, innovative, approach to chronic health along with some drugs/treatments (look at the timing on certain announcements) ready to go. If you turn government into a health and services organization, the political parties will fight over who provides and manages these services most effectively. At the end of the day, it's an argument. You can see the argument forming.
3 · Reply
HedgeAlerts
HedgeAlerts Nov. 14 at 6:16 PM
Hedge Alert Live - Protect Your Portfolio Contract: $ARDX $5.00 Put · NOV 21, 2025 Exp Entry Price: $0.05 - $0.11 Exit Price Target: $0.20 Profit Margin: +80% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
jaw02
jaw02 Nov. 14 at 6:03 PM
$ARDX Short and sweet article. 72% of surveyed healthcare pros have experienced disruption in their ability to prescribe PLT's since Jan. 1. https://aakp.org/fighting-for-his-health-a-care-partners-view-on-phosphate-management-and-kidney-disease/
2 · Reply
opportoni
opportoni Nov. 14 at 5:48 PM
$ARDX Janus reduced from 15 to about 13.8 million
1 · Reply
opportoni
opportoni Nov. 14 at 5:45 PM
$ARDX They fixed the Ardelyx feed.
2 · Reply
rawful
rawful Nov. 14 at 4:01 PM
$ARDX https://media.cadc.uscourts.gov/opinions/bydate/2025/11 The most recent decision(today) was argued on Sept 19. Ardelyx argued on Sept 25. Do we get an update soon?
2 · Reply
Cvong001
Cvong001 Nov. 14 at 3:56 PM
$ARDX is this page down? Can someone reply. The feed is not showing up for me. Stuck on “loading”
5 · Reply
ToadTrader
ToadTrader Nov. 14 at 3:18 PM
$ARDX
0 · Reply
ToadTrader
ToadTrader Nov. 14 at 1:58 PM
$ARDX $5.75 LOL.... Back to the core! I'm thinking as it is FRIDAY, sitting back and assessing Market Status, might be a focus for the day! Hot cereal and some great coffee has been the order of the morning! Remember.... There typically is a lot of shuffling going on in the General Market, this time of year.... with "Big Pockets", making efforts towards Portfolio Build Outs.... to take advantage of Tax issues! (I know about this as my Pro-Team that manages my "real investments" has been updating and reviewing these details, in alignment with property improvement and other budget planning!) All that, along with folks taking off time away for holiday travels and such are of influence towards things like daily volume and order flow! On the Small Account that I play with here, I'm still "tuning out" my skills towards "scalping" and tracking stocks via Chart Studies! It's what I do! Have fun... take time to review / write up your own trading plans..... Be Safe! CHEERS!
0 · Reply
M_OF_E
M_OF_E Nov. 14 at 1:30 PM
$ARDX Ibsrela TRx 4 week change up. Total Patients(4 week total) at a record. On the chart I posted pretty close to the center of the bottom and middle fan line. 4 week change in TRx about the same as last week, below the average 4 week change since launch, but the 4 week average of that change, is still above the yearly average. NRx weak. RRx strong. So scripts seem to be a little lumpy. Base for the next 2 weeks is strong so hopefully good numbers coming. Xphozah up on a 4 week basis. Not quite to the top of the recent range but Total Patients up near the top of the yearly range.
20 · Reply
TonySoprano1987
TonySoprano1987 Nov. 14 at 1:29 PM
$ARDX Mott isnt buying. Why should you?! Wait for $4.92 as first support
0 · Reply
TonySoprano1987
TonySoprano1987 Nov. 14 at 1:27 PM
$ARDX RED BABY!
1 · Reply
Burning_Cash
Burning_Cash Nov. 14 at 1:26 PM
$ARDX Looks like (the beginning of) a major shit storm in the market. We won't be spared, I fear, deserved or not.
3 · Reply
TonySoprano1987
TonySoprano1987 Nov. 14 at 11:56 AM
$ARDX the smell of $4.92 EOY
0 · Reply